{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:09:28Z","timestamp":1780463368840,"version":"3.54.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ijid.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T09:46:08Z","timestamp":1382435168000},"page":"4-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A quantitative survey of the literature on poliovirus infection and immunity"],"prefix":"10.1016","volume":"18","author":[{"given":"Matthew R.","family":"Behrend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima R.","family":"Nigmatulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Eckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.09.005_bib0005","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrmicro1769","article-title":"Vaccination against polio should not be stopped","volume":"5","author":"Chumakov","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0535","series-title":"Report of the Independent Monitoring Board of the Global Polio Eradication Initiative: February 2012","author":"Donaldson","year":"2012"},{"key":"10.1016\/j.ijid.2013.09.005_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.10.45","article-title":"Challenges faced by the global polio eradication initiative","volume":"9","author":"Wassilak","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2013.09.005_bib0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0030","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2013.09.005_bib0540","series-title":"Vaccines","article-title":"Poliovirus vaccine\u2014inactivated","author":"Vidor","year":"2013"},{"key":"10.1016\/j.ijid.2013.09.005_bib0545","series-title":"Vaccines","article-title":"Aylward RB. Poliovirus vaccine\u2014live","author":"Sutter","year":"2013"},{"key":"10.1016\/j.ijid.2013.09.005_bib0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/605330","article-title":"Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India","volume":"200","author":"Grassly Nicholas","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0050","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0055","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2013.09.005_bib0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.ijid.2013.09.005_bib0550","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"issue":"S1","key":"10.1016\/j.ijid.2013.09.005_bib0070","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/175.Supplement_1.S176","article-title":"Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature","volume":"175","author":"Alexander","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0080","series-title":"Expanded Program on Immunization. The immunological basis for immunization series: module 6\u2014poliomyelitis","author":"Robertson","year":"1993"},{"key":"10.1016\/j.ijid.2013.09.005_bib0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1088\/0026-1394\/43\/5\/009","article-title":"The expression of uncertainty in non-linear parameter estimation","volume":"43","author":"Balsamo","year":"2006","journal-title":"Metrologia"},{"key":"10.1016\/j.ijid.2013.09.005_bib0090","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/427810","article-title":"Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion","volume":"191","author":"Abbink","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/infdis\/168.5.1105","article-title":"Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine","volume":"168","author":"Abraham","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0100","first-page":"853","article-title":"Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin)","volume":"64","author":"Dong","year":"1986","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2013.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa0800390","article-title":"Monovalent type 1 oral poliovirus vaccine in newborns","volume":"359","author":"El-Sayed","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0110","first-page":"265","article-title":"Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity","volume":"5","author":"Ghendon","year":"1961","journal-title":"Acta Virol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.aje.a121058","article-title":"Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus type 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine","volume":"90","author":"Glezen","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.2.5247.272","article-title":"Vaccination of adults with a British oral poliomyelitis vaccine prepared from Sabin strains","volume":"2","author":"Goffe","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.ijid.2013.09.005_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0022172400040389","article-title":"A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine","volume":"64","author":"Henry","year":"1966","journal-title":"J Hyg (Lond.)"},{"key":"10.1016\/j.ijid.2013.09.005_bib0130","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0135","first-page":"513","article-title":"Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines","volume":"100","author":"Lu","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ijid.2013.09.005_bib0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/infdis\/175.3.545","article-title":"Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children","volume":"175","author":"Maldonado","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1096-9071(199705)52:1<50::AID-JMV9>3.0.CO;2-Q","article-title":"Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells","volume":"52","author":"Mallet","year":"1997","journal-title":"J Med Virol"},{"issue":"S1","key":"10.1016\/j.ijid.2013.09.005_bib0150","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","article-title":"The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years","volume":"12","author":"Nishio","year":"1984","journal-title":"J Biol Stand"},{"issue":"S2","key":"10.1016\/j.ijid.2013.09.005_bib0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/164.1.191","article-title":"Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines","volume":"6","author":"Ogra","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0170","unstructured":"PHLS. The excretion of type 1 poliovirus after challenge following primary immunization with quadruple, Salk and Sabin vaccines. Mon Bull Minist Health Public Health Lab Serv. Nov 1965;24:365-9."},{"key":"10.1016\/j.ijid.2013.09.005_bib0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0022172400055133","article-title":"The response to oral poliovaccine in persons aged 16\u201318 years","volume":"76","author":"Smith","year":"1976","journal-title":"J Hyg (Lond.)"},{"key":"10.1016\/j.ijid.2013.09.005_bib0555","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.vaccine.2007.12.021","article-title":"Intestinal immunity following a combined enhanced inactivated polio vaccine\/oral polio vaccine programme in Israel","volume":"26","author":"Swartz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2013.09.005_bib0560","series-title":"A small-scale trial on vaccination and revaccination with live attenuated polioviruses in the Netherlands","first-page":"355","author":"Verlinde","year":"1959"},{"key":"10.1016\/j.ijid.2013.09.005_bib0190","doi-asserted-by":"crossref","unstructured":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia, Oman, and Thailand. J Infect Dis 1997; 175(S1):S215\u201327.","DOI":"10.1093\/infdis\/175.Supplement_1.S215"},{"key":"10.1016\/j.ijid.2013.09.005_bib0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jama.1961.03040460001001","article-title":"Immunization of preschool children with oral poliovirus vaccine (Sabin)","volume":"178","author":"Horstmann","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2013.09.005_bib0200","doi-asserted-by":"crossref","unstructured":"Vaccine Administration Subcommittee. Evaluation of Sabin live poliovirus vaccine in Japan II. Clinical, virologic and immunological effects of vaccine in children. Jpn J Med Sci Biol 1966;19:277\u201391.","DOI":"10.7883\/yoken1952.19.277"},{"key":"10.1016\/j.ijid.2013.09.005_bib0205","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0264-410X(02)00523-6","article-title":"Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules","volume":"21","author":"Parent du Chatelet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2013.09.005_bib0210","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM200009143431103","article-title":"Trial of a supplemental dose of four poliovirus vaccines","volume":"343","author":"Sutter","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0215","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"Asturias Edwin","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.2.5247.266","article-title":"Vaccination against poliomyelitis with live virus vaccines 7. Effect of previous Salk vaccination on virus excretion","volume":"2","author":"Dick","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.ijid.2013.09.005_bib0225","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"Galindo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/oxfordjournals.aje.a120578","article-title":"Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1","volume":"83","author":"Glezen","year":"1966","journal-title":"Am J Epidemiol"},{"issue":"S1","key":"10.1016\/j.ijid.2013.09.005_bib0235","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1093\/infdis\/175.Supplement_1.S241","article-title":"Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992\u20131994","volume":"175","author":"Ion-Nedelcu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.aje.a120529","article-title":"Oral poliovirus vaccination in middle income families","volume":"82","author":"Kogon","year":"1965","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0245","first-page":"74","article-title":"The response and the lack of spread in Swedish school children given an attenuated poliovirus vaccine prepared in a human diploid cell strain","volume":"79","author":"Pagano","year":"1964","journal-title":"Am J Hyg"},{"key":"10.1016\/j.ijid.2013.09.005_bib0250","first-page":"85","article-title":"Intrafamilial and interfamilial spread of living vaccine strains of polioviruses","volume":"170","author":"Gelfand","year":"1959","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2013.09.005_bib0255","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0264-410X(98)00325-9","article-title":"Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus","volume":"17","author":"Piirainen","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2013.09.005_bib0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4049\/jimmunol.85.1.46","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana V. Passive transfer of polio antibody from mother to fetus and natural decline and disappearance of antibody in the infant","volume":"85","author":"Gelfand","year":"1960","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0265","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1542\/peds.23.6.1041","article-title":"Clinical trials in infants of orally administered attenuated poliomyelitis viruses","volume":"23","author":"Plotkin","year":"1959","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2013.09.005_bib0270","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0275","first-page":"85","article-title":"Early immunization of neonates with trivalent oral poliovirus vaccine","volume":"70","author":"Weckx","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2013.09.005_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5193(84)80010-7","article-title":"An immune response profile model for immunogenicity quantitation","volume":"110","author":"Smith","year":"1984","journal-title":"J Theor Biol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0285","first-page":"119","article-title":"Killed poliovirus antigen titration in humans","volume":"41","author":"Salk","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.ijid.2013.09.005_bib0290","unstructured":"Teunis PFM, van der Heijden OG, van derGiessen JWB, Havelaar AH. The dose-response relation in human volunteers for gastro-intestinal pathogens. Rijksinstituut voor Volksgezondheid en Milieu (Netherlands), 1996; Report no. 284550 002."},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2013.09.005_bib0295","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1093\/clinids\/6.Supplement_2.S352","article-title":"Modes of action of poliovirus vaccines and relation to resulting immunity","volume":"6","author":"Fox","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0300","first-page":"195","article-title":"Poliomyelitis vaccination of infants: preimmunization status and seroconversion","volume":"48","author":"Choudhury","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2013.09.005_bib0305","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2105\/AJPH.52.4.600","article-title":"Immunization of infants with the Sabin oral poliovirus vaccine","volume":"52","author":"Holguin","year":"1962","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ijid.2013.09.005_bib0310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1017\/S0022172400022567","article-title":"Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing sero-conversion rates","volume":"70","author":"Swartz","year":"1972","journal-title":"J Hyg (Lond.)"},{"key":"10.1016\/j.ijid.2013.09.005_bib0315","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0320","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006454-199603000-00006","article-title":"Effect of diarrhea on the humoral response to oral polio vaccination","volume":"15","author":"Myaux","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2013.09.005_bib0325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jmv.10480","article-title":"Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children","volume":"71","author":"Samoilovich","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.202.1.121","article-title":"Immunity of school children two years after oral poliomyelitis vaccination","volume":"202","author":"Lepow","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2013.09.005_bib0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00156819","article-title":"Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule","volume":"5","author":"Swartz","year":"1989","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.1959.03010080001001","article-title":"Use of orally administered live attenuated polioviruses as a vaccine in a community setting","volume":"170","author":"Barr","year":"1959","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2013.09.005_bib0345","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2013.09.005_bib0350","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0355","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006454-200206000-00011","article-title":"Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy","volume":"21","author":"Carlsson","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2013.09.005_bib0360","first-page":"312","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine","volume":"70","author":"Gelfand","year":"1959","journal-title":"Am J Hyg"},{"key":"10.1016\/j.ijid.2013.09.005_bib0365","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0370","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0910-769","article-title":"Improving the performance of enteric vaccines in the developing world","volume":"11","author":"Serazin","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0375","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(09)60950-8","article-title":"Child undernutrition, tropical enteropathy, toilets, and handwashing","volume":"374","author":"Humphrey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2013.09.005_bib0380","doi-asserted-by":"crossref","unstructured":"World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis 1995;171:1097\u2013106.","DOI":"10.1093\/infdis\/171.5.1097"},{"key":"10.1016\/j.ijid.2013.09.005_bib0385","first-page":"671","article-title":"Oral polio vaccination and factors affecting its efficacy","volume":"71","author":"Idris","year":"1980","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2013.09.005_bib0390","first-page":"1320","article-title":"Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines","volume":"146","author":"Faden","year":"1992","journal-title":"AJDC"},{"key":"10.1016\/j.ijid.2013.09.005_bib0395","first-page":"177","article-title":"Risk factors for persistent diarrhea among children under 2 years of age","volume":"30","author":"Deivanayagam","year":"1993","journal-title":"Case control study. Indian Pediatr"},{"key":"10.1016\/j.ijid.2013.09.005_bib0400","doi-asserted-by":"crossref","DOI":"10.3945\/jn.109.105312","article-title":"Landscape analysis of interactions between nutrition and vaccine responses in children","volume":"139","author":"Savy","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.ijid.2013.09.005_bib0405","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ijid.2013.09.005_bib0410","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case\u2013control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2013.09.005_bib0415","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJMoa0803259","article-title":"Effectiveness of immunization against paralytic poliomyelitis in Nigeria","volume":"359","author":"Jenkins","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0420","first-page":"61230","article-title":"Immunogenicity of bivalent type 1 and 3 oral poliovirus vaccine: a randomized, double-blind clinical trial","volume":"6736","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2013.09.005_bib0425","first-page":"977","article-title":"Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency","volume":"139","author":"Simoes","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ijid.2013.09.005_bib0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0435","first-page":"333","article-title":"Factors affecting the efficacy of live poliovirus vaccine in warm climates","volume":"51","author":"Domok","year":"1974","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2013.09.005_bib0440","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0264-410X(97)00001-7","article-title":"Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants","volume":"15","author":"Triki","year":"1997","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.ijid.2013.09.005_bib0445","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/175.Supplement_1.S258","article-title":"The effect of diarrhea on oral poliovirus vaccine failure in Brazil","volume":"175","author":"Posey","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0450","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics: I. The poor seroconversion rates and the absence of viral interference","volume":"96","author":"John","year":"1972","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0455","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0264-410X(95)00211-I","article-title":"Inactivated poliovirus vaccine: past and present experience","volume":"14","author":"Murdin","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2013.09.005_bib0460","first-page":"21","article-title":"Advantages and disadvantages of killed and live poliomyelitis vaccines","volume":"56","author":"Melnick","year":"1978","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2013.09.005_bib0475","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.162.8.5011","article-title":"Induction of mucosal immunity by inactivated poliovirus is dependent on previous mucosal contact with live virus","volume":"162","author":"Herremans","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/168.1.25","article-title":"Poliovirus vaccination: a trilogy","volume":"168","author":"Faden","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.09.005_bib0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","article-title":"Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter","volume":"86","author":"Benyesh-Melnick","year":"1967","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0480","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children","volume":"76","author":"Marine","year":"1962","journal-title":"Am J Hyg"},{"key":"10.1016\/j.ijid.2013.09.005_bib0565","series-title":"Vaccines","article-title":"Poliovirus vaccine\u2014live","author":"Sutter","year":"2008"},{"key":"10.1016\/j.ijid.2013.09.005_bib0490","first-page":"213","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2013.09.005_bib0495","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMe0806810","article-title":"Monovalent oral poliovirus vaccines\u2014a good tool but not a total solution","volume":"359","author":"Ehrenfeld","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0500","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.1115547","article-title":"OPV cessation\u2014the final step to a \u201cpolio-free\u201d world","volume":"310","author":"Aylward","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijid.2013.09.005_bib0505","unstructured":"World Health Organization. Framework for national policy makers in OPV-using countries. WHO\/POLIO\/05.02. Geneva: WHO; 2005."},{"key":"10.1016\/j.ijid.2013.09.005_bib0510","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1056\/NEJMp1005405","article-title":"The bumpy road to polio eradication","volume":"362","author":"Modlin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.09.005_bib0515","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: the OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ijid.2013.09.005_bib0520","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.8.1.5","article-title":"Role of injectable and oral polio vaccines in polio eradication","volume":"8","author":"John","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2013.09.005_bib0525","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/jama.1960.03020320001001","article-title":"Live, orally given poliovirus vaccine","volume":"173","author":"Sabin","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2013.09.005_bib0530","unstructured":"CDC assessment of risks to the global polio eradication initiative (GPEI) strategic plan 2010-2012.2011(4th quarter report): http:\/\/www.polioeradication.org\/Dataandmonitoring\/Polioeradicationtargets\/Riskassessments.aspx."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:16:32Z","timestamp":1688562992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121300297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":106,"alternative-id":["S120197121300297X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.09.005","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative survey of the literature on poliovirus infection and immunity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}